iver cancer ranks as the fourth most prevalent malignancy and serves as the second foremost cause of cancer-related mortality in China, representing a significant threat to public health and individual well-being. This book offers a comprehensive examination of the substantial advancements achieved in the clinical management of liver cancer within China over the past several decades. Notable milestones include the inaugural hepatectomy for liver cancer in China in 1958, the formulation of the liver anatomy theory distinguishing “five lobes and four segments,” and the utilization of alpha-fetoprotein in liver cancer screening. Furthermore, it encompasses continuous developments in theories and techniques pertinent to extensive liver cancer resections, alongside the evolution of multimodal treatment strategies that have become standard practice for managing liver cancer today.
The text also delves into emerging research concerning liver cancer biology, targeted therapies, and cancer immunotherapies being explored within China. Authored by distinguished experts in the field of liver cancer diagnosis and treatment, this work will serve as an invaluable resource for fellows, trainees, general practitioners, and specialists in hepatology, oncology, and hepato-biliary surgery.
